Related Experiment Video
Updated: Jun 13, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users
W Susan Cheng1, Richard S Garfein, Shirley J Semple
1Native American Alliance for Emergency Preparedness (NAAEP), California Department of Health Care Services, Davis, CA, USA.
Abstract:
Methamphetamine (MA) use has been found to be associated with increased risk of HIV and sexually transmitted infections (STI) among men having sex with men, but it is unknown whether those who inject MA are at greater risk for these infections than those who administer MA by other routes. Furthermore, comparable data from heterosexual MA users are lacking. We investigated whether the HIV and STI risks of male and female heterosexual MA users who inject MA differ from those of comparable users who do not inject. Between 2001 and 2005, we interviewed 452 HIV-negative men and women aged 18 and older who had recently used MA and engaged in unprotected sex. Their mean age was 36.6 years; 68% were male; ethnicity was 49.4% Caucasian, 26.8% African-American, and 12.8% Hispanic. Logistic regression identified factors associated with injecting MA. Compared to non-IDU, IDU were more likely to: be Caucasian; be homeless; have used MA for a longer period and used more grams of MA in the last 30 days; have a history of felony conviction; and report a recent STI. HIV and STI prevention interventions should be tailored according to MA users' method of administration.
Insights
Methamphetamine injectors face higher HIV and STI risks than non-injectors. Tailored prevention for methamphetamine users is crucial based on administration method.
Area of Science:
- Public Health
- Infectious Diseases
- Addiction Medicine
Background:
- Methamphetamine (MA) use is linked to increased HIV and sexually transmitted infection (STI) risks, particularly among men who have sex with men.
- Limited data exist on whether injecting MA (IDU) poses a greater risk than other administration routes.
- Comparable data for heterosexual MA users are lacking.
Purpose of the Study:
- To investigate if HIV and STI risks differ between heterosexual MA users who inject MA and those who do not.
- To identify factors associated with injecting MA among heterosexual users.
Main Methods:
- Cross-sectional study interviewing 452 HIV-negative heterosexual MA users (aged 18+) between 2001-2005.
- Participants reported recent MA use and unprotected sex.
- Logistic regression analysis identified factors associated with MA injection.
Main Results:
- Injecting MA users (IDU) were more likely to be Caucasian, homeless, have longer MA use history, and report recent STIs compared to non-IDU.
- IDU also reported using more grams of MA in the last 30 days and had a history of felony conviction.
- Recent STI diagnosis was significantly associated with MA injection.
Conclusions:
- MA injection is associated with higher HIV and STI risks among heterosexual users.
- Prevention interventions for MA users should be tailored based on their method of administration (injection vs. non-injection).
Related Concept Videos
Amebiasis
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
